Along with the new name the biotechnology company has changed its trading symbol from NHGI to PROTD. The new identity was chosen to reflect Proteonomix’s focus on proteomics, which is the large scale study of proteins.
Moving from research to the marketplace
The changes also mark the moment when Proteonomix moves beyond research into commercial product development.
Last month the company launched a range of anti-aging products based on stem cells through its subsidiary Proteoderm that it presented at the International Anti-Aging Conference in Washington D.C.
The line, which includes five skin care products, incorporates tropelastin secreted from human embryonic stem cells.
Science behind stem cell cosmetics
Proteonomix claims the ingredient enhances the natural formation of collagen and binds with existing protein chains in the skin to make it appear smoother and firmer.
Tropelastin already affects skin appearance naturally in pregnant women.
Proteonomix CEO Michael Cohen told CosmeticsDesign.com that the inspiration for the products came from the natural glow of women post-conception that is caused by the release of the chemical from embryonic stem cells.
Proteonomix said the response to the launch has so far been encouraging but that it is only the beginning for the company.